News
We bring you up to date at all times: Discover the latest industry news from biotechnology, pharmaceuticals and life sciences. Researched by us so you don't have to.
Selected departments
Selected industries
Companies
The Who's Who of Life Sciences: Discover companies from all over the world. Here you can easily find the provider matching your search, including contact options.
Selected countries
Selected companies
Products
The first stop for your procurement process: discover innovative products for lab and process that make your everyday life easier and solve even complex challenges.
Products of selected companies
White papers
What could be better than an application problem that has already been solved by others? Tap into in-depth application knowledge from proven experts. Conveniently via download to your device.
Most read white papers
White papers of selected companies
Webinars
Exciting lectures and practical application tips via video, whenever you want: Our on-demand webinars make it possible. Make yourself comfortable and click play.
Selected webinars
Webinars of selected companies
Knowledge & education
Question. Answer. Find articles on 57,945 keywords in life science, biotech, pharma, biology and related science disciplines in the encyclopedia..
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Note
The function "Store search" is only available to registered users.
Important information
Currently, you are not logged in to my.bionity.com. Therefore, you can remember a maximum of 5 contents.
FILTER
Refine your search with the following facets to narrow down your results.
12-Nov-2007 - Dyax Corp. announced the extension of the antibody library collaboration with ImClone Systems Incorporated for the discovery of therapeutic antibodies. Under the terms of this agreement, ImClone will continue to have access to Dyax's proprietary phage display technology for an additional four ...
07-Sep-2007 - Dyax Corp. announced that they have entered into an agreement with Bayer Schering Pharma AG for the discovery of therapeutic antibodies. Under the terms of this agreement, Dyax will identify therapeutic antibodies for two targets provided by Bayer Schering Pharma. Furthermore, these research ...
06-Aug-2007 - Dyax Corp. announced that they have licensed their antibody phage display libraries to Cambridge Antibody Technology (CAT), a wholly-owned subsidiary of AstraZeneca, for the discovery of therapeutic antibodies. CAT will receive sublicenses to relevant third-party antibody phage display patents ...
19-Jul-2007 - Organon announced that they have entered into an agreement with Dyax Corp. to discover and develop human therapeutic antibodies for the treatment of auto-immune diseases and cancer. Under the terms of the agreement, Dyax will utilize its proprietary phage display technology to identify antibodies ...
24-May-2007 - Dyax Corp. announced that Trubion Pharmaceuticals, Inc. has exercised an option to expand its existing research agreement, which covers protein therapeutics and diagnostics discovery. In addition to the ongoing multiple-target funded research project, Dyax will now transfer its proprietary phage ...
03-May-2007 - Dyax Corp. announced that the United States Patent and Trademark office issued U.S. Patent No. 7,208,293, Dyax's seventh U.S. patent covering its proprietary protein display technology. This new patent provides Dyax with additional patent claims that cover methods for selecting binding proteins, ...
14-Mar-2007 - Dyax Corp. and Glenmark Pharmaceuticals S.A., the wholly-owned Swiss subsidiary of Glenmark Pharmaceuticals Ltd., announced that they have entered into a funded research agreement for the discovery of therapeutic antibodies. Under the terms of this agreement, Dyax will perform funded research to ...
Dyax Secures 100% Ownership to DX-88 in All Indications
22-Feb-2007 - Dyax Corp. announced that it has reached a mutual agreement with Genzyme Corporation to terminate their joint venture for the development and commercialization of DX-88 for hereditary angioedema (HAE). The termination agreement stipulates that Dyax will receive all the assets of the joint ...
11-Jan-2007 - Dyax Corp. announced that the United States Patent and Trademark office has issued two U.S. Patents relating to its program for on-pump cardiothoracic surgery (CTS). U.S. Patent No. 7,153,829 (issued December 26, 2006) covers methods for preventing or reducing perioperative blood loss due to ...
01-Dec-2006 - Dyax Corp. and the Division of Molecular and Health Technologies of the Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australia's national scientific research agency, announced that they have entered into a collaboration for the discovery and development of therapeutic ...
© 1997-2024 LUMITOS AG, All rights reserved